Compare Cadila Healthcare with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs SUN PHARMA - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE SUN PHARMA CADILA HEALTHCARE/
SUN PHARMA
 
P/E (TTM) x 24.6 76.0 32.4% View Chart
P/BV x 4.3 3.2 133.2% View Chart
Dividend Yield % 0.8 0.7 121.9%  

Financials

 CADILA HEALTHCARE   SUN PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-20
SUN PHARMA
Mar-20
CADILA HEALTHCARE/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs352484 72.8%   
Low Rs207315 65.5%   
Sales per share (Unadj.) Rs139.2136.9 101.7%  
Earnings per share (Unadj.) Rs11.817.5 67.4%  
Cash flow per share (Unadj.) Rs18.626.0 71.4%  
Dividends per share (Unadj.) Rs3.504.00 87.5%  
Dividend yield (eoy) %1.31.0 125.2%  
Book value per share (Unadj.) Rs101.4188.7 53.7%  
Shares outstanding (eoy) m1,023.742,399.26 42.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.02.9 68.7%   
Avg P/E ratio x23.722.9 103.7%  
P/CF ratio (eoy) x15.015.4 97.9%  
Price / Book Value ratio x2.82.1 130.1%  
Dividend payout %29.822.9 129.8%   
Avg Mkt Cap Rs m286,033958,864 29.8%   
No. of employees `00013.417.8 75.5%   
Total wages/salary Rs m24,14563,624 37.9%   
Avg. sales/employee Rs Th10,632.718,490.6 57.5%   
Avg. wages/employee Rs Th1,801.23,582.6 50.3%   
Avg. net profit/employee Rs Th898.52,357.6 38.1%   
INCOME DATA
Net Sales Rs m142,531328,375 43.4%  
Other income Rs m1,1396,360 17.9%   
Total revenues Rs m143,670334,735 42.9%   
Gross profit Rs m24,19869,898 34.6%  
Depreciation Rs m6,96520,528 33.9%   
Interest Rs m3,4183,027 112.9%   
Profit before tax Rs m14,95452,702 28.4%   
Minority Interest Rs m2880-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-2,606 0.0%   
Tax Rs m3,1988,228 38.9%   
Profit after tax Rs m12,04441,868 28.8%  
Gross profit margin %17.021.3 79.8%  
Effective tax rate %21.415.6 137.0%   
Net profit margin %8.512.8 66.3%  
BALANCE SHEET DATA
Current assets Rs m87,154316,542 27.5%   
Current liabilities Rs m82,694157,064 52.6%   
Net working cap to sales %3.148.6 6.4%  
Current ratio x1.12.0 52.3%  
Inventory Days Days7188 81.6%  
Debtors Days Days94105 89.6%  
Net fixed assets Rs m133,236243,102 54.8%   
Share capital Rs m1,0242,399 42.7%   
"Free" reserves Rs m102,733450,245 22.8%   
Net worth Rs m103,757452,645 22.9%   
Long term debt Rs m32,14620,289 158.4%   
Total assets Rs m236,866682,525 34.7%  
Interest coverage x5.418.4 29.2%   
Debt to equity ratio x0.30 691.2%  
Sales to assets ratio x0.60.5 125.1%   
Return on assets %6.56.6 99.2%  
Return on equity %11.69.2 125.5%  
Return on capital %13.711.2 122.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m52,75274,219 71.1%   
Fx outflow Rs m14,50427,964 51.9%   
Net fx Rs m38,24846,255 82.7%   
CASH FLOW
From Operations Rs m25,05465,548 38.2%  
From Investments Rs m-10,123-25,888 39.1%  
From Financial Activity Rs m-10,942-57,151 19.1%  
Net Cashflow Rs m3,989-13,857 -28.8%  

Share Holding

Indian Promoters % 74.8 63.7 117.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 5.1 161.8%  
FIIs % 5.9 23.0 25.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 8.3 132.5%  
Shareholders   44,069 133,026 33.1%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   NOVARTIS  ASTRAZENECA PHARMA  DISHMAN PHARMA  IPCA LABS  JUBILANT LIFE SCIENCES  

Compare CADILA HEALTHCARE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 257 Points Higher, Coal India and UPL Among Top Gainers(Closing)

Indian share markets continued their positive trend during closing hours today and ended their day on a firm note.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 40.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 40.6% YoY). Sales on the other hand came in at Rs 38 bn (up 4.3% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)

Oct 26, 2020 | Updated on Oct 26, 2020

Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

More Views on News

Most Popular

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Penny Stock Master Series: The Quest for 10X Profits in 10 Years(Profit Hunter)

Feb 12, 2021

This is first of the three part master series. In these editorials, I'll show you how to earn 10X returns from a penny stock portfolio over 10 years.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Feb 25, 2021 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE - WOCKHARDT COMPARISON

COMPARE CADILA HEALTHCARE WITH

MARKET STATS